trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Foubister V Anticancer drug shows promise against lupus. 2003 Drug Discov. Today pmid:12681930
Park WH et al. Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis. 2003 Int. J. Oncol. pmid:12684681
Schauber J et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. 2003 Gut pmid:12692061
Rambhatla L et al. Generation of hepatocyte-like cells from human embryonic stem cells. 2003 Cell Transplant pmid:12693659
Lee SC et al. Activation of terminal B cell differentiation by inhibition of histone deacetylation. 2003 Mol. Immunol. pmid:12695118
Zika E et al. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. 2003 Mol. Cell. Biol. pmid:12697811
Mihaylova VT et al. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. 2003 Mol. Cell. Biol. pmid:12697826
Valenta T et al. HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells. 2003 Nucleic Acids Res. pmid:12711682
Arora T et al. PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4. 2003 J. Biol. Chem. pmid:12716907
Yasui W et al. Histone acetylation and gastrointestinal carcinogenesis. 2003 Ann. N. Y. Acad. Sci. pmid:12724227
Jedrusik MA and Schulze E Telomeric position effect variegation in Saccharomyces cerevisiae by Caenorhabditis elegans linker histones suggests a mechanistic connection between germ line and telomeric silencing. 2003 Mol. Cell. Biol. pmid:12724425
Farhan H et al. Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells. 2003 J. Steroid Biochem. Mol. Biol. pmid:12732287
Chambers AE et al. Histone acetylation-mediated regulation of genes in leukaemic cells. 2003 Eur. J. Cancer pmid:12736119
Hoever G et al. The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells. 2003 Int. J. Mol. Med. pmid:12736716
Swank RA et al. The histone deacetylase inhibitor, trichostatin A, reactivates the developmentally silenced gamma globin expression in somatic cell hybrids and induces gamma gene expression in adult BFUe cultures. 2003 May-Jun Blood Cells Mol. Dis. pmid:12737942
Craig JM et al. Centromeric chromatin pliability and memory at a human neocentromere. 2003 EMBO J. pmid:12743043
Enright BP et al. Epigenetic characteristics and development of embryos cloned from donor cells treated by trichostatin A or 5-aza-2'-deoxycytidine. 2003 Biol. Reprod. pmid:12748129
Van Ommeslaeghe K et al. Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition. 2003 Bioorg. Med. Chem. Lett. pmid:12749885
Zhao S et al. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. 2003 Cancer Res. pmid:12750289
Klisovic DD et al. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. 2003 Invest. Ophthalmol. Vis. Sci. pmid:12766035
Génin P et al. Impairment of interferon-induced IRF-7 gene expression due to inhibition of ISGF3 formation by trichostatin A. 2003 J. Virol. pmid:12768031
Bartoli A et al. Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells. 2003 Pharmacol. Res. pmid:12770523
Koeller KM et al. Chemical genetic modifier screens: small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation. 2003 Chem. Biol. pmid:12770822
Agoulnik IU et al. Repressors of androgen and progesterone receptor action. 2003 J. Biol. Chem. pmid:12771131
Kang J et al. Nickel-induced histone hypoacetylation: the role of reactive oxygen species. 2003 Toxicol. Sci. pmid:12773760
Maatouk DM and Resnick JL Continuing primordial germ cell differentiation in the mouse embryo is a cell-intrinsic program sensitive to DNA methylation. 2003 Dev. Biol. pmid:12781693
Ju R and Muller MT Histone deacetylase inhibitors activate p21(WAF1) expression via ATM. 2003 Cancer Res. pmid:12782595
Chua YL et al. The transcriptional enhancer of the pea plastocyanin gene associates with the nuclear matrix and regulates gene expression through histone acetylation. 2003 Plant Cell pmid:12782737
Cecconi D et al. Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A. 2003 Electrophoresis pmid:12783462
Park KK et al. Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter. 2003 Biochem. Biophys. Res. Commun. pmid:12788094
Marks J et al. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter. 2003 J. Biol. Chem. pmid:12791684
Valls E et al. The SV40 T antigen modulates CBP histone acetyltransferase activity. 2003 Nucleic Acids Res. pmid:12799439
Ferguson M et al. Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene. 2003 Nucleic Acids Res. pmid:12799440
Ji Y et al. A multistep mechanism for the activation of rearrangement in the immune system. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12802019
Nemajerová A et al. Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells. 2003 J. Hematother. Stem Cell Res. pmid:12804181
Park PH et al. Acetylation of histone H3 at lysine 9 by ethanol in rat hepatocytes. 2003 Biochem. Biophys. Res. Commun. pmid:12804592
Méndez-Pertuz M et al. The thyroid hormone receptor antagonizes CREB-mediated transcription. 2003 EMBO J. pmid:12805224
Illi B et al. Shear stress-mediated chromatin remodeling provides molecular basis for flow-dependent regulation of gene expression. 2003 Circ. Res. pmid:12805238
Bhakat KK and Mitra S CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. 2003 Carcinogenesis pmid:12807730
Lopatina NG et al. Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells. 2003 Biochem. Biophys. Res. Commun. pmid:12810068
Liu LT et al. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. 2003 Cancer Res. pmid:12810630
Shin HJ et al. Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation. 2003 Oncogene pmid:12813458
Kim TY et al. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. 2003 Oncogene pmid:12813468
Kim H et al. The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor. 2003 Am. J. Respir. Cell Mol. Biol. pmid:12816733
Klan N et al. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity. 2003 Biol. Chem. pmid:12817474
Yamada Y et al. Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer. 2003 Cancer Sci. pmid:12824880
Kim JM et al. Changes in histone acetylation during mouse oocyte meiosis. 2003 J. Cell Biol. pmid:12835313
Ammanamanchi S et al. Acetylated sp3 is a transcriptional activator. 2003 J. Biol. Chem. pmid:12837748
James SY et al. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells. 2003 Cancer Res. pmid:12839938
Krämer OH et al. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. 2003 EMBO J. pmid:12840003
Cho B et al. Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. 2003 Biochem. Biophys. Res. Commun. pmid:12849980
Pivot-Pajot C et al. Acetylation-dependent chromatin reorganization by BRDT, a testis-specific bromodomain-containing protein. 2003 Mol. Cell. Biol. pmid:12861021
Grassi G et al. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. 2003 Carcinogenesis pmid:12869421
Marshall S et al. Enhanced expression of uridine diphosphate-N-acetylglucosaminyl transferase (OGT) in a stable, tetracycline-inducible HeLa cell line using histone deacetylase inhibitors: kinetics of cytosolic OGT accumulation and nuclear translocation. 2003 Anal. Biochem. pmid:12871726
Koch A et al. Mitogen-activated protein kinase modulation of nuclear factor-kappaB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages. 2004 Am. J. Respir. Cell Mol. Biol. pmid:12871851
McGhee L et al. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. 2003 J. Cell. Biochem. pmid:12874834
Chun AC and Jin DY Transcriptional regulation of mitotic checkpoint gene MAD1 by p53. 2003 J. Biol. Chem. pmid:12876282
Grisolano JL et al. An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12881486
Konduri SD et al. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. 2003 Oncogene pmid:12881707
Condon JC et al. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12886011
Ryu JR and Arnosti DN Functional similarity of Knirps CtBP-dependent and CtBP-independent transcriptional repressor activities. 2003 Nucleic Acids Res. pmid:12888527
Mulholland NM et al. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation. 2003 Oncogene pmid:12894222
Banwell CM et al. Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation. 2003 Recent Results Cancer Res. pmid:12899515
Yan Y et al. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. 2003 Toxicol. Appl. Pharmacol. pmid:12902198
Augenlicht L et al. Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation. 2003 Oncogene pmid:12902981
Kishikawa S et al. Roles of histone acetylation in the Dnmt1 gene expression. 2002 Nucleic Acids Res. Suppl. pmid:12903179
Massillon D et al. Regulation of glucose-6-phosphatase gene expression in cultured hepatocytes and H4IIE cells by short-chain fatty acids: role of hepatic nuclear factor-4alpha. 2003 J. Biol. Chem. pmid:12915406
Hong CY et al. Expression of MIS in the testis is downregulated by tumor necrosis factor alpha through the negative regulation of SF-1 transactivation by NF-kappa B. 2003 Mol. Cell. Biol. pmid:12917325
Le Masson I et al. Yaf9, a novel NuA4 histone acetyltransferase subunit, is required for the cellular response to spindle stress in yeast. 2003 Mol. Cell. Biol. pmid:12917332
Adam E et al. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha. 2003 Mol. Cell. Biol. pmid:12917341
Zhong S et al. Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A. 2003 Oncogene pmid:12917630
Cao H et al. Induction of human gamma globin gene expression by histone deacetylase inhibitors. 2004 Blood pmid:12920038
Nakajima M et al. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells. 2003 Toxicol. Lett. pmid:12927368
Papeleu P et al. Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes. 2003 J. Hepatol. pmid:12927923
Senawong T et al. Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. 2003 J. Biol. Chem. pmid:12930829
Fass DM et al. Deacetylase activity is required for cAMP activation of a subset of CREB target genes. 2003 J. Biol. Chem. pmid:12939274
Zhao C et al. A composite motif of the Drosophila morphogenetic protein bicoid critical to transcription control. 2003 J. Biol. Chem. pmid:12939280
Hinoi T et al. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. 2003 J. Biol. Chem. pmid:12947088
Nakano M et al. Epigenetic assembly of centromeric chromatin at ectopic alpha-satellite sites on human chromosomes. 2003 J. Cell. Sci. pmid:12953060
Kim EJ et al. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML. 2003 Nucleic Acids Res. pmid:12954772
Brugarolas JB et al. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. 2003 Cancer Cell pmid:12957289
Fukuoka M et al. Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. 2003 Int. J. Mol. Med. pmid:12964026
Vanommeslaeghe K et al. Ab initio study of the binding of Trichostatin A (TSA) in the active site of histone deacetylase like protein (HDLP). 2003 Org. Biomol. Chem. pmid:12968347
Huang H et al. [HDAC1 expression and effect of TSA on proliferation and apoptosis of A549 cells]. 2003 Ai Zheng pmid:12969522
Ohike N et al. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. 2003 Cancer Lett. pmid:12969792
Cimini D et al. Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects. 2003 Mol. Biol. Cell pmid:12972566
Schuettengruber B et al. Autoregulation of mouse histone deacetylase 1 expression. 2003 Mol. Cell. Biol. pmid:12972616
Yang Y et al. The histone code regulating expression of the imprinted mouse Igf2r gene. 2003 Endocrinology pmid:12975326
Hu E et al. Identification of novel isoform-selective inhibitors within class I histone deacetylases. 2003 J. Pharmacol. Exp. Ther. pmid:12975486
Xu Y et al. SHP-1 sensitizes MCF-7 cells to trichostatin A-induced apoptosis by modulating PI3K-dependent events. 2003 Cell Death Differ. pmid:14502244
Donadelli M et al. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. 2003 Mol. Carcinog. pmid:14502645
Tominaga K et al. MRGX is a novel transcriptional regulator that exhibits activation or repression of the B-myb promoter in a cell type-dependent manner. 2003 J. Biol. Chem. pmid:14506250
Kawai H et al. Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. 2003 Int. J. Cancer pmid:14506733
Kishikawa S et al. Control elements of Dnmt1 gene are regulated in cell-cycle dependent manner. 2003 Nucleic Acids Res. Suppl. pmid:14510503
Wegener D et al. Improved fluorogenic histone deacetylase assay for high-throughput-screening applications. 2003 Anal. Biochem. pmid:14511685
Remiszewski SW et al. N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824). 2003 J. Med. Chem. pmid:14521422
Noh EJ and Lee JS Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition. 2003 Biochem. Biophys. Res. Commun. pmid:14521905
Li C et al. Effect and comparison of sodium butyrate and trichostatin A on the proliferation/differentiation of K562. 2003 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:14526425
Margueron R et al. Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells. 2003 J. Endocrinol. pmid:14529564
Kagoshima M et al. How signaling pathways interact with gene transcription. 2003 Jan-Mar Monaldi Arch Chest Dis pmid:14533280